APOE4 Splits Alzheimer’s Into Two Neurochemical Diseases, PET Imaging Study Reveals
A study of 387 amyloid-confirmed patients shows APOE4 carriers suffer cholinergic basal forebrain degeneration while non-carriers show dopaminergic loss, defining ...
